Changes in procoagulant and fibrinolytic gene expression during bleomycin-induced lung injury in the mouse.
about
Alveolar epithelial type II cell: defender of the alveolus revisitedReciprocal regulation of TGF-β and reactive oxygen species: A perverse cycle for fibrosisThe Rho kinases: critical mediators of multiple profibrotic processes and rational targets for new therapies for pulmonary fibrosisPlasminogen activator inhibitor type 1 up-regulation is associated with skeletal muscle atrophy and associated fibrosisFAK-related nonkinase is a multifunctional negative regulator of pulmonary fibrosis.Tissue factor-deficiency and protease activated receptor-1-deficiency reduce inflammation elicited by diet-induced steatohepatitis in mice.Transforming growth factor-β1 induces expression of human coagulation factor XII via Smad3 and JNK signaling pathways in human lung fibroblasts.Plasminogen activator inhibitor-1 is a major stress-regulated gene: implications for stress-induced thrombosis in aged individuals.Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodelingFibrin turnover in lung inflammation and neoplasia.Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditionsAnticoagulants for acute respiratory distress syndrome: can they work?Prolonged exposure to sphingosine 1-phosphate receptor-1 agonists exacerbates vascular leak, fibrosis, and mortality after lung injury.Role of the urokinase-fibrinolytic system in epithelial-mesenchymal transition during lung injury.The plasminogen activation system reduces fibrosis in the lung by a hepatocyte growth factor-dependent mechanism.TRPV4 mediates myofibroblast differentiation and pulmonary fibrosis in mice.Vitronectin-binding PAI-1 protects against the development of cardiac fibrosis through interaction with fibroblastsFibrin-induced skin fibrosis in mice deficient in tissue plasminogen activator.Adult respiratory distress syndrome: do selective anticoagulants help?Disorders of lung matrix remodeling.Therapeutic value of small molecule inhibitor to plasminogen activator inhibitor-1 for lung fibrosis.Increased plasminogen activator inhibitor-1 in keloid fibroblasts may account for their elevated collagen accumulation in fibrin gel culturesThe kidneys of mice with autoimmune disease acquire a hypofibrinolytic/procoagulant state that correlates with the development of glomerulonephritis and tissue microthrombosisKinetics of lung tissue factor expression and procoagulant activity in bleomycin induced acute lung injury.A total fibrinogen deficiency is compatible with the development of pulmonary fibrosis in mice.Regulation of alveolar epithelial cell apoptosis and pulmonary fibrosis by coordinate expression of components of the fibrinolytic systemInhibition of Plasminogen Activator Inhibitor-1 Attenuates Transforming Growth Factor-β-Dependent Epithelial Mesenchymal Transition and Differentiation of Fibroblasts to Myofibroblasts.The alveolar epithelium can initiate the extrinsic coagulation cascade through expression of tissue factorPAI-1 promotes the accumulation of exudate macrophages and worsens pulmonary fibrosis following type II alveolar epithelial cell injury.Procoagulant signalling mechanisms in lung inflammation and fibrosis: novel opportunities for pharmacological intervention?Regulation of alveolar procoagulant activity and permeability in direct acute lung injury by lung epithelial tissue factor.Using mouse genomics to understand idiopathic interstitial fibrosis.Oxidative stress, plasminogen activator inhibitor 1, and lung fibrosisGlutathione suppresses TGF-beta-induced PAI-1 expression by inhibiting p38 and JNK MAPK and the binding of AP-1, SP-1, and Smad to the PAI-1 promoter.Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease.The fibrinolytic system and the regulation of lung epithelial cell proteolysis, signaling, and cellular viability.Plasminogen activator inhibitor-1 in acute hyperoxic mouse lung injury.Prostaglandin E2 mediates IL-1beta-related fibroblast mitogenic effects in acute lung injury through differential utilization of prostanoid receptors.Plasminogen activator inhibitor-1 antagonist TM5441 attenuates Nω-nitro-L-arginine methyl ester-induced hypertension and vascular senescence.Sphingolipid regulation of tissue fibrosis
P2860
Q24791750-DA6614F5-93AA-4C51-9A44-DF83C36A8D82Q26779846-A84333A1-7047-4D3C-991E-399817A0E103Q27005980-72953B78-5032-4217-B560-71E76C0D09FDQ28566526-90C63BCF-07F1-4C53-9C99-4EE347720CC6Q30413255-6F0AEF2D-D74F-4AD0-BFF1-B6EB4CBA50CDQ33556288-347B4114-5661-45F7-8936-E8C9A6609E76Q33799846-DA0EC2C8-A6A1-4CFB-A38B-6D6391266159Q33894605-4C000CF3-344B-4AD5-8D00-0F61B64E383EQ33930863-C35B5ECB-1683-41F2-8EA1-1EA5EC9A154BQ34141236-FC3718E3-2BC8-451F-945A-E1800B3FBC1CQ34217461-581EAC73-C6C9-47CA-AAA1-1187C7FCCA04Q34345363-7F9820F0-214E-4CC6-A48D-4FCB8BDD065EQ34357097-01D8191E-F561-47D2-9E33-E0C57D29D589Q34780769-BDA86CE5-34EF-422B-A5F7-073F97584A2FQ35096108-3C07F997-8F87-4346-8ADA-AEB5401421DEQ35145453-474CB302-351A-4FBF-B9ED-4DD2878F470DQ35180538-F4A5CB25-7804-43E4-A1A4-148CCF218689Q35221823-609A883D-AF9A-4A6F-A1AE-3F19EF2A16D7Q35627757-4C807697-3ABD-4D38-9C42-FB2916822068Q35628568-71D63369-55F1-42F9-869A-850CD532B062Q35684759-71F722D9-2367-4438-AC5D-B05826442F52Q35749077-A8BA7512-2171-4C05-A67F-710421AFCECCQ35763454-521CAA58-14BB-4ED1-A9FB-730E90B3BDA4Q35829051-F7766669-FB8C-4573-88D9-D8C048326142Q35829481-CE1DFA7A-E87A-4874-BE20-31D1091F16C5Q35850241-F86577F9-58BF-435A-85D0-5A007E46BD62Q35918076-F8F58096-2C0B-4B3F-9B32-86EA329FECE8Q36225788-DFFE3B41-8EA4-4F9E-A35B-B6F887FEA1D8Q36486253-4BA12F81-9926-4EFD-90FE-3018D88DF4E8Q36497048-1CD96CC5-D0E6-48F9-A39C-835474557DBDQ36549153-CA48DF76-3693-40E7-8DE5-8A8916EE5B2CQ36698831-665E5B8E-CBA9-4208-A410-C4488F06C4FBQ36940906-B41C3B75-6EC2-4D7B-A5B0-DF12CCE4632AQ36940924-718AC751-233B-4F80-B462-E67192B3B36FQ37133224-E0F4C445-CD21-4231-810A-CFD0E6014D82Q37286882-99D945B9-A503-45B9-8648-9C7863AEAFD8Q37362031-05DD1A9E-CA69-4055-81A2-9B324E695E3AQ37462187-07395303-3A34-4A79-B64C-62AFD27825F5Q37600695-93775A79-47DF-4987-B0B2-F47EBBB51630Q38026843-3AE939A6-642F-4062-BACA-2B041C4C3F64
P2860
Changes in procoagulant and fibrinolytic gene expression during bleomycin-induced lung injury in the mouse.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Changes in procoagulant and fi ...... uced lung injury in the mouse.
@ast
Changes in procoagulant and fi ...... uced lung injury in the mouse.
@en
type
label
Changes in procoagulant and fi ...... uced lung injury in the mouse.
@ast
Changes in procoagulant and fi ...... uced lung injury in the mouse.
@en
prefLabel
Changes in procoagulant and fi ...... uced lung injury in the mouse.
@ast
Changes in procoagulant and fi ...... uced lung injury in the mouse.
@en
P2093
P2860
P356
P1476
Changes in procoagulant and fi ...... uced lung injury in the mouse.
@en
P2093
C L Gladson
D J Loskutoff
P2860
P304
P356
10.1172/JCI118201
P407
P577
1995-09-01T00:00:00Z